P01.150 hypermutations in glioblastoma are associated with increased response to immunotherapy

BACKGROUND: Glioblastomas (GBM) exhibit a hyper mutable phenotype only in a restricted subset harboring somatic or germinal mutations of mismatch-repair (MMR) genes. Immunotherapy (IT), including dendritic cell (DC) vaccination and inhibition of immune checkpoints, are actively pursued in GBM patien...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Anghileri, E, Zhao, J, Eoli, M, Langella, T, Pollo, B, Indraccolo, S, Pellegatta, S, Iavarone, A, Rabadan, R, Finocchiaro, G
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Poster Presentations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.192
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia